Similar articles

• Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies.

  Imai K, Ng AK, Glassy MC, Ferrone S. Imai K, et al. J Immunol. 1981 Aug;127(2):505-9. J Immunol. 1981. PMID: 6166672
• Melanoma and immunity.

  Rheins LA, Nordlund JJ. Rheins LA, et al. Immunol Ser. 1989;46:769-87. Immunol Ser. 1989. PMID: 2484957 Review. No abstract available.
• Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.

  de Vries JE, Spits H. de Vries JE, et al. J Immunol. 1984 Jan;132(1):510-9. J Immunol. 1984. PMID: 6197458
• Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.

  Zennadi R, Abdel-Wahab Z, Seigler HF, Darrow TL. Zennadi R, et al. Cell Immunol. 2001 Jun 15;210(2):96-105. doi: 10.1006/cimm.2001.1809. Cell Immunol. 2001. PMID: 11520076
• Identification of tumor-regression antigens in melanoma.

  Kawakami Y, Robbins PF, Wang RF, Rosenberg SA. Kawakami Y, et al. Important Adv Oncol. 1996:3-21. Important Adv Oncol. 1996. PMID: 8791125 Review. No abstract available.